Evidence map›Paper›PMID 40562493›Full record

ArticleJACC. Basic to translational science2025

Cannabidiol Prevents Heart Failure Dysfunction and Remodeling Through Preservation of Mitochondrial Function and Calcium Handling.

Gerardo García-Rivas, Omar Lozano, Judith Bernal-Ramírez, Christian Silva-Platas, Felipe Salazar-Ramírez, Abraham Méndez-Fernández, Carolina Morales-Ochoa, Hugo Alves-Figueiredo, Martín Rogelio Ramos-González, Nestor Rubio-Infante and 10 more

Abstract read
In one paragraph

Article in JACC. Basic to translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Gerardo García-RivasTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico; Tecnologico de Monterrey, Institute for Obesity Research, Monterrey, Mexico. Electronic address: gdejesus@tec.mx.
Omar LozanoTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico; Tecnologico de Monterrey, Institute for Obesity Research, Monterrey, Mexico.
Judith Bernal-RamírezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico; Tecnologico de Monterrey, Institute for Obesity Research, Monterrey, Mexico.
Christian Silva-PlatasTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico.
Felipe Salazar-RamírezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico.
Abraham Méndez-FernándezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico.
Carolina Morales-OchoaTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico.
Hugo Alves-FigueiredoTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico.
Martín Rogelio Ramos-GonzálezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico.
Nestor Rubio-InfanteTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico.
Eduardo Vázquez-GarzaTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico.
Luis A Luévano-MartínezTecnologico de Monterrey, Institute for Obesity Research, Monterrey, Mexico.
Silvia López-MoránTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico.
Héctor Chapoy-VillanuevaTecnologico de Monterrey, Institute for Obesity Research, Monterrey, Mexico.
James BoltonCardiol Therapeutics Inc, Ontario, Canada.
José-Luis Velasco-BolomTecnologico de Monterrey, Institute for Obesity Research, Monterrey, Mexico.
Paola Mendoza-EspinosaTecnologico de Monterrey, Institute for Obesity Research, Monterrey, Mexico.
Flavio F Contreras-TorresTecnologico de Monterrey, Institute for Obesity Research, Monterrey, Mexico; Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Monterrey, Mexico.
Carlos Jerjes-SánchezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico.
Guillermo Torre-AmioneTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico; Tecnologico de Monterrey, Institute for Obesity Research, Monterrey, Mexico; The Methodist Hospital, Cornell University, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) is characterized by energy deprivation, calcium (Ca

Indexed as

Ca(2+) dynamicscannabidiolheart failuremitochondrial energeticsoxidative stressPPAR-γ

Identifiers

PMID40562493
PMCPMC12230462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.